Airway ManagementNCT06955884
Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation
An observational study of Airway Management and Fiberoptic Guided Intubation, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.
Trial summary
Airway management problems are key drivers for anesthesia-related adverse events. Awake tracheal intubation using flexible bronchoscopy and preserved spontaneous breathing (ATI:FB) is a recommended technique to manage difficult tracheal intubation in anaesthesia, intensive care and emergency medicine. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Airway Management, Fiberoptic Guided Intubation, Patient Experience
- How many people
- 198 participants
- Where
- 1 siteGermany
- Study dates
- 30 Jun 2025to 15 Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients scheduled for surgery requiring general anaesthesia at the study center university hospital medical center
Who may be able to join
- patients scheduled for surgery requiring tracheal intubation
- patients with an anticipated difficult airway requiring ATI:FB
- consent by the patient
- minimum 18 years of age
Who cannot join
- patients scheduled for surgery requiring tracheal intubation
- patients not scheduled for ATI:FB
- pregnant or breastfeeding patients
- consent withheld or not possible to obtain by the patient
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Germany1 site, 1 recruiting
- Recruiting
University Medical Center Hamburg-Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, 20246
Martin Petzoldt, M.D., +4915222815932, m.petzoldt@uke.de
Vera Köhl, M.D., v.koehl@uke.de
About this study
Official title: Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation With Flexible Bronchoscopy - an Observational Study
Airway management problems are key drivers for anesthesia-related adverse events. Awake tracheal intubation using flexible bronchoscopy and preserved spontaneous breathing (ATI:FB) is a recommended technique to manage difficult tracheal intubation in anaesthesia, intensive care and emergency medicine. ATI:FB is regarded as the gold standard of tracheal intubation in many scenarios, however there is insufficient data on the patients experience while undergoing this form of airway management. ATI:FB can be facilitated using either a transnasal or transoral route. The study aims to compare patient-centred and operator-focused outcome parameters between these two different approaches with a focus on patient discomfort.
- Keywords
- airway management, flexible endoscopy guided intubation, patient discomfort
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Transnasal ATI:FB | Patients undergoing airway management via the transnasal route | |
| Transoral ATI:FB | Patients undergoing airway management via the transoral route |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient reported discomfort experienced during ATI:FB
recorded on a visual analog scale (1-100; lower values better)
Measured: 24 hours after anaesthesia
Secondary outcomes (38)
Patient reported recall of the ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported pain experienced during ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported fear experienced during ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported feeling of suffocation experienced during ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported dyspnea experienced during ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported distress experienced during ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported coughing experienced after ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported dry throat experienced after ATI:FB?
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported hoarseness experienced after ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported sleeping problems experienced after ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported occurrence of nightmares experienced after ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: 24 hours after airway management
Patient reported preoperative expectation of discomfort to be experienced during ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Measured: during preoperative assessment
Patient reported preoperative fear of airway management
yes/no and on a visual analog scale (1-100; lower values better)
Measured: during preoperative assessment
First attempt success
number of participants with successful ATI:FB with only one attempt
Measured: 1 hour
Number of bronchoscopy attempts
Observed during airway management
Measured: 1 hour
Number of intubation attempts
Observed during airway management
Measured: 1 hour
Successful ATI:FB
Number of participants with successful ATI:FB
Measured: 1 hour
Successful bronchoscopy
Number of participants with successful bronchoscopy
Measured: 1 hour
Successful tube placement
Number of participants with successful tracheal tube placement
Measured: 1 hour
Conversion from transnasal to transoral bronchoscopy or vice versa
Observed during airway management
Measured: 1 hour
Conversion to another type of airway management
Observed during airway management
Measured: 1 hour
Percentage of glottic opening
Grading of the best view obtained during laryngoscopy (%)
Measured: 1 hour
Glottic view
Grading of the best view obtained using landmarks (6 stages)
Measured: 1 hour
Time to best glottic view
Recorded during airway management
Measured: 1 hour
Time to intubation
Recorded during airway management
Measured: 1 hour
Lowest oxygen saturation
Measured during airway management (%)
Measured: 1 hour
Endtidal CO2
First value measured after intubation in mmHg
Measured: 1 hour
Airway obstructions requiring external manipulation
yes/no
Measured: 1 hour
Hypoxia
Lowest peripheral oxygen saturation measured by pulsoximetry in %
Measured: 1 hour
Cardiovascular event requiring intervention (hypotension/bradycardia)
Observed during airway management
Measured: 1 hour
Cardiovascular event requiring intervention (hypertension, tachycardia)
Observed during airway management
Measured: 1 hour
Additional manoeuvres and adjuncts
Observed during airway management
Measured: 1 hour
Airway-related complications
Recorded during airway management
Measured: 1 hour
Anaesthesia alert card issue
Recorded after airway management
Measured: 1 hour
Recommendation for future airway management
Recorded after airway management
Measured: 1 hour
Richmond Agitation-Sedation Scale
Observed during airway management (-5 to 4; lower values indicate deeper sedation)
Measured: 1 hour
Subjective reporting of difficulty of sedation, topicalisation, bronchoscopy and tube placement
On a visual analog scale (1-100)
Measured: 1 hour
Preparation time
Recorded during airway management
Measured: 1 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 May 2025
- Study start30 Jun 2025
- Primary completion30 Nov 2025 (estimated)
- Study completion15 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Airway ManagementStudies of the same condition, open and under way.
- More trials run by Universitätsklinikum Hamburg-EppendorfThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 198 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06955884
- Sponsor's protocol ID
- 2025-101503-BO-ff
- Other IDs
- 2025
- Status last verified
- Jul 2025
- First submitted
- 22 Apr 2025
- Last updated
- 10 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation With Flexible Bronchoscopy - an Observational Study
- ClinicalTrials.gov ID
- NCT06955884
- Acronym / sponsor ID
- 2025-101503-BO-ff
- Keywords
- airway management, flexible endoscopy guided intubation, patient discomfort
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 198 participants (estimated)
- Lead sponsor
- Universitätsklinikum Hamburg-EppendorfUniversity, hospital or other
- Study start
- 30 Jun 2025 (actual)
- Primary completion
- 30 Nov 2025 (estimated)
- Study completion
- 15 Dec 2025 (estimated)
- First posted
- 2 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Airway management problems are key drivers for anesthesia-related adverse events. Awake tracheal intubation using flexible bronchoscopy and preserved spontaneous breathing (ATI:FB) is a recommended technique to manage difficult tracheal intubation in anaesthesia, intensive care and emergency medicine. ATI:FB is regarded as the gold standard of tracheal intubation in many scenarios, however there is insufficient data on the patients experience while undergoing this form of airway management. ATI:FB can be facilitated using either a transnasal or transoral route. The study aims to compare patient-centred and operator-focused outcome parameters between these two different approaches with a focus on patient discomfort.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Transnasal ATI:FB | – | –Patients undergoing airway management via the transnasal route |
| Transoral ATI:FB | – | –Patients undergoing airway management via the transoral route |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients scheduled for surgery requiring general anaesthesia at the study center university hospital medical center
Key inclusion criteria (4 listed)
- patients scheduled for surgery requiring tracheal intubation
- patients with an anticipated difficult airway requiring ATI:FB
- consent by the patient
- minimum 18 years of age
Key exclusion criteria (4 listed)
- patients scheduled for surgery requiring tracheal intubation
- patients not scheduled for ATI:FB
- pregnant or breastfeeding patients
- consent withheld or not possible to obtain by the patient
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Patient reported discomfort experienced during ATI:FB
Time frame: 24 hours after anaesthesia
recorded on a visual analog scale (1-100; lower values better)
38 secondary outcomes
Patient reported recall of the ATI:FB
Time frame: 24 hours after airway management
Patient reported pain experienced during ATI:FB
Time frame: 24 hours after airway management
Patient reported fear experienced during ATI:FB
Time frame: 24 hours after airway management
Patient reported feeling of suffocation experienced during ATI:FB
Time frame: 24 hours after airway management
Patient reported dyspnea experienced during ATI:FB
Time frame: 24 hours after airway management
Patient reported distress experienced during ATI:FB
Time frame: 24 hours after airway management
Patient reported coughing experienced after ATI:FB
Time frame: 24 hours after airway management
Patient reported dry throat experienced after ATI:FB?
Time frame: 24 hours after airway management
Patient reported hoarseness experienced after ATI:FB
Time frame: 24 hours after airway management
Patient reported sleeping problems experienced after ATI:FB
Time frame: 24 hours after airway management
Patient reported occurrence of nightmares experienced after ATI:FB
Time frame: 24 hours after airway management
Patient reported preoperative expectation of discomfort to be experienced during ATI:FB
Time frame: during preoperative assessment
Patient reported preoperative fear of airway management
Time frame: during preoperative assessment
First attempt success
Time frame: 1 hour
Number of bronchoscopy attempts
Time frame: 1 hour
Number of intubation attempts
Time frame: 1 hour
Successful ATI:FB
Time frame: 1 hour
Successful bronchoscopy
Time frame: 1 hour
Successful tube placement
Time frame: 1 hour
Conversion from transnasal to transoral bronchoscopy or vice versa
Time frame: 1 hour
Conversion to another type of airway management
Time frame: 1 hour
Percentage of glottic opening
Time frame: 1 hour
Glottic view
Time frame: 1 hour
Time to best glottic view
Time frame: 1 hour
Time to intubation
Time frame: 1 hour
Lowest oxygen saturation
Time frame: 1 hour
Endtidal CO2
Time frame: 1 hour
Airway obstructions requiring external manipulation
Time frame: 1 hour
Hypoxia
Time frame: 1 hour
Cardiovascular event requiring intervention (hypotension/bradycardia)
Time frame: 1 hour
Cardiovascular event requiring intervention (hypertension, tachycardia)
Time frame: 1 hour
Additional manoeuvres and adjuncts
Time frame: 1 hour
Airway-related complications
Time frame: 1 hour
Anaesthesia alert card issue
Time frame: 1 hour
Recommendation for future airway management
Time frame: 1 hour
Richmond Agitation-Sedation Scale
Time frame: 1 hour
Subjective reporting of difficulty of sedation, topicalisation, bronchoscopy and tube placement
Time frame: 1 hour
Preparation time
Time frame: 1 hour
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Airway Management
Not yet recruiting
Tizanidine Premedication Versus Placebo for Laryngeal Mask Airway Insertion and Recovery in Adults Undergoing Ambulatory Surgery
Airway Management
Not yet recruitingObservational study
AI-assisted Tracheal Intubation in Children
Intubation
Recruiting
Comparing Surfactant Administration Through Supraglottic Airway and Thin Catheter for Preterm Infants
Surfactant, Respiratory Distress Syndrome (Neonatal)
Not yet recruitingObservational study
Preoperative Frailty and Suboptimal Mask Ventilation in Cardiac Surgery Patients
Frailty, Suboptimal Mask Ventilation
Not yet recruitingPhase 2
A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Disease, Chronic Obstructive
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Airway Management and Fiberoptic Guided Intubation, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient reported discomfort experienced during ATI:FB (time frame: 24 hours after anaesthesia). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2025.